Gene Therapy in Parkinson Disease: From Preclinical Studies in Primates to a Phase I Clinical Trial

被引：0
|
作者：
Jarraya, B. [1 ,3 ]
Lepetit, H. [3 ]
Ralph, S. [2 ]
Miskin, J. [2 ]
Gurruchaga, J-M [3 ]
Fenelon, G. [3 ]
Boulet, S. [1 ]
Jan, C. [1 ]
Bonvento, G. [1 ]
Azzouz, M. [5 ]
Brugiere, P. [3 ]
Kingsman, S. [2 ]
Naylor, S. [2 ]
Hantraye, P. [1 ]
Remy, P. [1 ,3 ]
Mazarakis, N. D. [4 ]
Mitrophanous, K. [2 ]
Palfi, S. [1 ,3 ]
机构：
[1] CEA CNRS MirCen, Fontenay Aux Roses, France
[2] Oxford BioMed UK Ltd, Oxford, England
[3] Univ Paris, Hop Henri Mondor, Paris, France
[4] Univ London Imperial Coll Sci Technol & Med, Div Med, Dept Gene Therapy, London SW7 2AZ, England
[5] Univ Sheffield, Sch Med, Neurol Unit, Sheffield S10 2TN, S Yorkshire, England
来源：
HUMAN GENE THERAPY | 2010年 / 21卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：764 / 765
页数：2
相关论文
共 50 条
  • [1] ProSavin® a Gene Therapy Approach for Parkinson Disease: Phase I Clinical Trial Update
    Palfi, S.
    Jarraya, B.
    Gurruchaga, J-M
    Ralph, S.
    Lepetit, H.
    Lavisse, S.
    Miskin, J.
    Kas, A.
    Fenelon, S.
    Brugiere, P.
    Kingsman, S.
    Naylor, S.
    Hantraye, P.
    Remy, K.
    Mitrophanous, K.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1364 - 1364
  • [2] Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
    Eberling, J. L.
    Jagust, W. J.
    Christine, C. W.
    Starr, P.
    Larson, P.
    Bankiewicz, K. S.
    Aminoff, M. J.
    NEUROLOGY, 2008, 70 (21) : 1980 - 1983
  • [3] ProSavin® a Dopamine Gene Therapy Approach for Parkinson's Disease: Phase I Clinical Trial
    Palfi, S.
    Gurruchaga, J. -M.
    Ralph, G. S.
    Watts, C.
    Buttery, P.
    Scorer, S.
    Lepetit, H.
    Miskin, J.
    Iwamuro, H.
    Lavisse, S.
    Kas, A.
    Ramelli, A. L.
    Tani, N.
    Dolphin, P.
    Fenelon, G.
    Brugiere, P.
    Kingsman, S.
    Naylor, S.
    Hantraye, P.
    Remy, P.
    Barker, R.
    Mitrophanous, K.
    CELL TRANSPLANTATION, 2013, 22 (05) : 911 - 911
  • [4] ProSavin® a Gene Therapy Approach for Parkinson's Disease: Phase I Clinical Trial Update
    Palfi, Stephane
    Watts, Colin
    Gurrachaga, Jean-Marc
    Buttery, Philip
    Ralph, Scott
    Deeley, Saray
    Lepetit, Helene
    Miskin, James
    Iwamuro, Hirokazu
    Lavisse, Sonia
    Kas, Aurelie
    Ramelli, Anne Laure
    Tani, Naoki
    Dolphin, Patrice
    Abhay, K.
    Gabriel, I.
    Fenelon, Gilles
    Brugiere, Pierre
    Naylor, Stuart
    Hantraye, Philippe
    Remy, Philippe
    Barker, Roger
    Mitrophanous, Kyriacos
    MOLECULAR THERAPY, 2012, 20 : S23 - S23
  • [5] Gene therapy of myotubular myopathy: from preclinical studies to a clinical trial
    Bello, A. Buj
    HUMAN GENE THERAPY, 2018, 29 (12) : A11 - A12
  • [6] ProSavin® a Gene Therapy Approach for the Treatment of Parkinson's Disease: Phase I Clinical Trial Update
    Palfi, S.
    Gurruchaga, J-M
    Scorer, S.
    Ralph, S.
    Lepetit, H.
    Jarraya, B.
    Miskin, J.
    Iwamuro, H.
    Lavisse, S.
    Ramelli, A. L.
    Tani, N.
    Dolphin, P.
    Abhay, K.
    Gabriel, I.
    Fenelon, G.
    Brugiere, P.
    Kingsman, S.
    Price, G.
    Naylor, S.
    Hantraye, P.
    Remy, P.
    Mitrophanous, K.
    HUMAN GENE THERAPY, 2011, 22 (10) : A20 - A20
  • [7] ProSavin® a gene therapy approach for the treatment of Parkinson's Disease: a Phase I Clinical Trial Update
    Palfi, Stephane
    Watts, Collin
    Marc, Gurruchaga Jean
    Peter, Buttery
    Scott, Ralph
    Sarah, Deeley
    Helene, Lepetit
    James, Miskin
    Hiro, Iwamuro
    Sonia, Lavisse
    Aurelie, Kas
    Laure, Ramelli Anne
    Naoki, Tani
    Gilles, Fenelon
    Pierre, Brugie're
    Stuart, Naylor
    Philippe, Hantraye
    Philippe, Remy
    Roger, Barker
    Kyriacos, Mitrophanous
    HUMAN GENE THERAPY, 2012, 23 (10) : A61 - A61
  • [8] More on gene therapy for Parkinson's disease: An open label, phase I trial
    Mckhann, Guy M., II
    NEUROSURGERY, 2007, 61 (03) : N6 - N7
  • [9] Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease
    Urbinati, Fabrizia
    Wherley, Jennifer
    Geiger, Sabine
    Fernandez, Beatriz Campo
    Kaufman, Michael L.
    Cooper, Aaron
    Romero, Zulema
    Marchioni, Filippo
    Reeves, Lilith
    Read, Elizabeth
    Nowicki, Barbara
    Grassman, Elke
    Viswanathan, Shivkumar
    Wang, Xiaoyan
    Hollis, Roger P.
    Kohn, Donald B.
    CYTOTHERAPY, 2017, 19 (09) : 1096 - 1112
  • [10] A phase I/II clinical trial to evaluate the safety and efficacy of ProSavin®, a gene therapy approach for Parkinson's disease
    Jarraya, B.
    Lepetit, H.
    Ralph, S.
    Boulet, S.
    Jan, C.
    Bonvento, G.
    Miskin, J.
    Gurruchaga, J. -M.
    Vinti, M.
    Fenelon, G.
    Brugiere, P.
    Kingsman, S.
    Hantraye, P.
    Remy, P.
    Mitrophanous, K.
    Palfi, S.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S145 - S145
12345